Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

USP24 is a cross-reactive DUB targeting MOV10 to regulate IFN-I production.

Nature communications·2026

Same author

Structure Merging Approach Leads to New Dual Potent and Selective USP25/USP28 Inhibitors.

Journal of medicinal chemistry·2026

Same author

Leveraging Targeted Protein Degradation for G Protein-Coupled Receptors: The Development of CCR2 Molecular Degraders.

Journal of medicinal chemistry·2025

Same author

High-Throughput Synthesis and Screening of a Cyanimide Library Identifies Selective Inhibitors of ISG15-Specific Protease mUSP18.

Angewandte Chemie (International ed. in English)·2025

Same author

Membrane Contact Sites in Proteostasis and ER Stress Response.

Contact (Thousand Oaks (Ventura County, Calif.))·2025

Same author

Advancing the Exploration of the Ubiquitin-like Protein FUBI with Synthetic Chemical Tools.

Chembiochem : a European journal of chemical biology·2025

Search research articles

相关实验视频

Updated: Jul 19, 2025

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

对DUB抑制剂进行基于板块的查.

Stephan Scherpe¹, Aysegul Sapmaz¹, Monique P C Mulder²

¹Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands.

Methods in molecular biology (Clifton, N.J.)

|August 9, 2023

概括

研究人员开发了一种新的检测方法,用于选向二维基化酶 (DUBs) 的小分子抑制剂. 这种工具有助于开发用于与不平衡无处不在相关的疾病的药物.

科学领域:

生物化学生物化学
分子生物学分子生物学
药物发现药物发现药物发现

背景情况:

乌比基 (Ub) 是一个关键的翻译后修饰剂,调节许多细胞过程.
调节不良的无处不在与各种人类疾病有关.
消除乌比奎的除乌比奎酶 (DUBs) 被认为是重要的治疗点.

研究的目的:

开发和验证一种可靠的测定方法,用于针对DUB的小分子抑制剂的高通量选.
促进发现新型治疗药物,治疗与异常无处不在性相关的疾病.

主要方法:

开发一个用于DUB活动评估的新型测试平台.
实施小分子抑制剂查协议.
对药物发现的强度和适用性进行测试验证.

主要成果:

成功建立了用于选DUB抑制剂的可靠试验.
该试验表明,该试验适合识别选择性DUB向化合物.
这个平台有可能加速基于DUB的治疗方法的发展.

结论:

开发的试验是一种有价值的工具,用于识别DUBs的小分子抑制剂.

关键词:

这里是 DUBs.消毒化酶消毒化酶抑制剂抑制剂抑制剂查检查查检查查检查乌比奎丁是一种存在的药物.

更多相关视频

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

相关实验视频

Last Updated: Jul 19, 2025

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

这种查平台可以为开发针对性治疗与ubiquitination相关疾病的开发做出重大贡献.

针对DUBs是未来药物开发的一个有希望的战略.